Cor­den­Phar­ma in­jects €900M to boost GLP-1 man­u­fac­tur­ing in US and Eu­rope

In its biggest in­vest­ment so far, Cor­den­Phar­ma is ear­mark­ing €900 mil­lion ($982 mil­lion) over the next three years to ex­pand its pep­tide plat­form ca­pac­i­ty in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER